A cross-sectional study analyzing Safety of SARS-CoV-2 vaccination in patients with Behcet's syndrome and familial Mediterranean fever
Latest Information Update: 07 Jun 2022
At a glance
- Drugs SARS-COV-2 vaccine-inactivated-Sinovac-Biotech (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Adverse reactions
Most Recent Events
- 07 Jun 2022 New trial record
- 01 Jun 2022 Results published in the Rheumatology International